Parker Waichman LLP

FDA Issues Safety Alert for Bioprosthetic Aortic Valves Because of Reduced Leaflet Motion

In a safety alert issued on October 5, the Food and Drug Administration (FDA) noted recent reports of reduced leaflet motion in some bioprosthetic aortic valves, including both SAVR (surgical aortic valve replacement) and TAVR (transaortic valve replacement) devices. Most cases of reduced leaflet motion were discovered by advanced imaging studies in patients without symptoms […]

FDA Issues Safety Alert for Bioprosthetic Aortic Valves

FDA Issues Safety Alert for Bioprosthetic Aortic Valves

In a safety alert issued on October 5, the Food and Drug Administration (FDA) noted recent reports of reduced leaflet motion in some bioprosthetic aortic valves, including both SAVR (surgical aortic valve replacement) and TAVR (transaortic valve replacement) devices.

Most cases of reduced leaflet motion were discovered by advanced imaging studies in patients without symptoms of abnormal bioprosthetic valve function. Further, these studies have shown that in valves with reduced motion of one or more individual leaflets, there was acceptable forward blood flow through the valve opening without evidence of stenosis (narrowing), according to the FDA.

The definitive cause(s) of reduced leaflet motion in some bioprosthetic aortic valves is not known. Evidence from imaging studies suggests that blood clot (thrombus) deposits on the leaflets may cause restricted motion. The prevalence of reduced leaflet motion was less in patients taking the anticoagulant warfarin compared with those receiving sub-therapeutic or no anticoagulant and with those receiving dual anti-platelet therapy.

In one study, blood thinning medications (anticoagulants) resolved the leaflet motion abnormalities.

The FDA believes that bioprosthetic aortic valves remain reasonably safe and effective when used according to their approved indications. This view is supported by the favorable benefit/risk profile observed in SAVR devices in the 30 years they have been on the market and in TAVR devices in the eight years they have been in use. Based on the currently available data “the FDA believes that the benefits of using these devices for the currently approved indications continue to outweigh the risks.”

Overall, six strokes occurred in studies reported in the New England Journal of Medicine but all occurred within 24 hours of implantation, suggesting that “these first-day strokes were related to the procedural aspects of TAVR rather than to leaflet thrombosis,” according to Medpage Today. The investigators acknowledged the possibility that patients receiving bioprosthetic valves may be at higher risk for “leaflet thrombosis and consequent embolic stroke than has previously been recognized.” In an editorial accompanying the article, Dr. David Holmes of the Mayo Clinic and Dr. Michael Mack of Baylor Scott and White Health in Plano, Texas, wrote that “given the rapid clinical adoption of TAVR” the new findings are “extremely important,” though “clear scientific answers are still lacking.”

The FDA said the reports have raised important questions about bioprosthetic aortic valves. But limited data do not allow FDA to fully characterize the causes, incidence, and short and long-term risks of reduced valve leaflet motion, or to recommend appropriate treatment. The FDA is working with the American College of Cardiology, the Society of Thoracic Surgeons, and the device manufacturers to design clinical studies to fully evaluate reduced valve leaflet motion for all types of bioprosthetic aortic valves.

For patients who have a bioprosthetic aortic valve, additional diagnostic imaging using 3D or 4D CT or TEE may be considered when clinically indicated. If reduced leaflet motion is found, the FDA advises that treatment options should be discussed with the team of heart physicians responsible for the patient’s care.

 

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
I had a very good experience with the people at PW. No issues at all
Peggy Corrigan
4 years ago
5 Star Reviews 150
When I contacted Parker Waichman LLC I did not know what to expect…But I met Ms Benita Rollis and she was a Godsend ! Ms Rollis guided me through the entire process.. and whenever I had a question about anything Ms Rollis got back to me with answers immediately! I dont know what I would have done without Ms Benita Rollis .. She is the BEST ! Thank you. I have dealt with other Law Firms over the years But nobody tops Parker Waichman.
Kevin Oras
2 years ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness , Value All of the above. I am very please with service that was rendered to me especially by Christina Morace who was on point with every questions that I asked her. She was very professional and above all very helpful to me. I will gladly recommend your company to anyone who needs a excellent Law Firm.
Bixley Simpson
2 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038